Know Labs (NYSEAMERICAN:KNW) Trading Up 3.8% – What’s Next?

Shares of Know Labs, Inc. (NYSEAMERICAN:KNW) traded up 3.8% on Monday . The company traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Stock Performance

The stock has a market capitalization of $16.04 million, a P/E ratio of -0.33 and a beta of 1.83. The business has a fifty day simple moving average of $2.14 and a 200-day simple moving average of $2.14.

Institutional Investors Weigh In On Know Labs

A hedge fund recently bought a new position in Know Labs stock. Corient Private Wealth LLC purchased a new stake in Know Labs, Inc. (NYSEAMERICAN:KNW) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 50,000 shares of the company’s stock, valued at approximately $99,000. Corient Private Wealth LLC owned approximately 0.67% of Know Labs at the end of the most recent quarter. 23.96% of the stock is owned by institutional investors and hedge funds.

About Know Labs

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.